Effect of cytochromeP450 2C19genotype on voriconazole exposure in cystic fibrosis lung transplant patients
✍ Scribed by Maud Berge; Romain Guillemain; David A. Trégouet; Catherine Amrein; Veronique Boussaud; Patrick Chevalier; Agnes Lillo-Lelouet; Christine Le Beller; Pierre Laurent-Puig; Philippe H. Beaune; Eliane M. Billaud; Marie-Anne Loriot
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 266 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Aerosolized recombinant human DNase (dornase alfa) reduces mucus viscoelasticity in vitro and improves pulmonary function in patients with cystic fibrosis (CF). We postulated that if dornase alfa could be delivered more peripherally to small airways in the lung in the form of smaller aerosol droplet
The aim of the study was to measure the effect of a short course of recombinant human deoxyribonuclease I (rhDNase) on ciliary and cough clearance in a group of cystic fibrosis patients, using a radioaerosol and gamma camera technique. Patients were initially randomized to receive either rhDNase (2.